TABLE 4.
Symptoms Reported by CASES Project Participants by Reactivity Versus Non-Reactivity to Anti-SARS-CoV-2 Antibodies (N=264)
| Non-Reactive (n = 253) | Antibody Reactive (n = 11) | P-Value | |
| Ever any symptomsa | 116 (45.8) | 8 (72.7) | 0.0804 |
| Any symptoms 3 months ago (April) | 57 (22.5) | 6 (54.5) | 0.0249∗ |
| Any symptoms 2 months ago (May) | 39 (15.4) | 4 (36.4) | 0.0849 |
| Any symptoms 1 month ago (June) | 74 (29.2) | 5 (45.5) | 0.3132 |
| Any of the following symptoms (ever vs never) | |||
| Shortness of breath or difficulty breathing | 18 (7.1) | 5 (45.5) | 0.0011∗ |
| Coughing | 38 (15.0) | 6 (54.5) | 0.0037∗ |
| Headache | 71 (28.2) | 5 (50.0) | 0.1597 |
| Fever >100 °F | 14 (5.6) | 6 (54.5) | <0.0001∗ |
| Chills | 16 (6.3) | 4 (36.4) | 0.0057∗ |
| Repeated shaking with chills (rigors) | 7 (2.8) | 2 (18.2) | 0.0485∗ |
| Muscle pain (unrelated to exercise or vigorous activities) | 21 (8.5) | 3 (27.3) | 0.0678 |
| Sore throat | 47 (19.0) | 5 (45.5) | 0.0446∗ |
| Loss of taste or smell | 8 (3.2) | 5 (45.5) | <0.0001∗ |
| Gastrointestinal symptoms, such as nausea or diarrhea | 43 (17.0) | 5 (45.5) | 0.0316∗ |
| Other symptoms2 | 9 (3.6) | 3 (27.3) | 0.0097∗ |
All values are given as n (%) unless otherwise specified.
All variables have complete data except (variable [missing no. non-reactive, missing no. reactive]): headache [1,1]; fever more than 100° [2,0]; muscle pain [1,0]; sore throat [1,0]; loss of taste or smell [2,0].
a
Excludes “Other symptoms”.
b
Other symptoms include: rash, allergies, sore neck, shingles, light-headedness, acid reflux, nasal drip, fatigue, high pitch ringing in ears, burning/red eyes, lung rattling during inhalation.
∗
P-values <0.05 considered statistically significant.